The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery. [PDF]
Ruchi R +5 more
europepmc +1 more source
Lysosomal Ion Channels and Transporters: Recent Findings, Therapeutic Potential, and Technical Approaches. [PDF]
Kondratskyi A +23 more
europepmc +1 more source
Losartan API and Nitrosamines Impurities-Stability Profile Investigation Using HPLC, LC-MS, and In Silico Assessment. [PDF]
Martini PRR +6 more
europepmc +1 more source
Toward an Extensible Regulatory Framework for N-of-1 to N-of-Few Personalized RNA Therapy Design. [PDF]
Bou-Jaoudeh M +3 more
europepmc +1 more source
Developing a scoring system for gene curation prioritization in lysosomal diseases. [PDF]
Vernet Machado Bressan Wilke M +14 more
europepmc +1 more source
Wide-field OCT angiography for non-human primate retinal imaging. [PDF]
Wei X +4 more
europepmc +1 more source
Integrating N-of-1 Trials Into Learning Health Care Systems. [PDF]
Brown JEH, Chiong W, Hutchinson N.
europepmc +1 more source
Towards Novel Antiplasmodial Agents-Design, Synthesis and Antimalarial Activity of Second-Generation β-Carboline/Chloroquine Hybrids. [PDF]
Penava A +7 more
europepmc +1 more source
Elevated tripeptidyl-peptidase 1 corrects multiple disease phenotypes in a mouse model of juvenile neuronal ceroid lipofuscinosis. [PDF]
Banach-Petrosky W +10 more
europepmc +1 more source

